Related Experiment Videos
Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human
1Division of Physics and Biochemical Sciences, Ente per le nuove technologie per l'energia e l'ambiente (ENEA), Rome, Italy.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|October 1, 1991
Summary
An antisense oligodeoxynucleotide targeting the MYCN oncogene reduced MYCN protein levels in neuroblastoma cells. This inhibition decreased cell replication and promoted differentiation, suggesting MYCN
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Neuroblastoma is a pediatric cancer often associated with MYCN gene amplification.
- The MYCN oncogene plays a critical role in neuroblastoma development and progression.
Purpose of the Study:
- To investigate the effects of targeting MYCN oncogene expression in human neuroblastoma cells.
- To determine the role of MYCN in cell proliferation and differentiation.
Main Methods:
- Utilized an antisense oligodeoxynucleotide (AS-ON) against MYCN codons 2-7.
- Assessed MYCN protein expression and synthesis using immunoperoxidase staining and immunoprecipitation.
- Evaluated cell replication rate and phenotypic changes.
Main Results:
- AS-ON treatment significantly decreased MYCN protein expression and synthesis in LAN-5 cells.
- Inhibition of MYCN led to reduced cellular replication rates.
- Neuroblastoma cells exhibited a shift towards a more differentiated phenotype.
Conclusions:
- The MYCN oncogene is implicated in regulating both the proliferative and differentiative processes in neuroblastoma.
- Targeting MYCN oncogene expression holds potential therapeutic implications for neuroblastoma treatment.